Salvage Treatment for Progressive Brain Metastases in Breast Cancer

SIMPLE SUMMARY: Thirty percent of patients with human epidermal growth factor receptor 2-positive breast cancer and triple-negative breast cancer, and 15% of patients with the remaining subtypes of breast cancer will develop brain metastases. Available treatment methods include surgery and radiother...

Descripción completa

Detalles Bibliográficos
Autores principales: Spałek, Mateusz Jacek, Mandat, Tomasz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870695/
https://www.ncbi.nlm.nih.gov/pubmed/35205844
http://dx.doi.org/10.3390/cancers14041096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870695/
https://www.ncbi.nlm.nih.gov/pubmed/35205844
http://dx.doi.org/10.3390/cancers14041096

Ejemplares similares